Charles S. CleelandメーカーThe Brief Pain Inventory iiの使用説明書/サービス説明書
ページ先へ移動 of 36
The Brie f Pain Inv ento ry User Gu ide Char les S. Cleelan d, P hD ii C opyright a nd T erms o f Us e The B rie f Pa in In vento ry (BPI) copy righ t is held b y Dr. C harles S. C leelan d (19 91) . The c opyri gh t appl ies to t he BPI a nd all it s der iv at iv es in an y l ang ua ge.
i Tab l e of Con ten ts C hap te r 1 ... ....... ....... ....... ........ ....... ....... ....... .... ....... . 1 D evel opm ent o f th e Br ie f P ain In v en to ry ...... ....... . 1 Ba ckgr ound ..... ....... ....... ....... ........ ....... .....
1 Chapt er 1 De ve l op m en t o f th e Br ie f P a in I n ven tor y The B rie f Pa in In vento ry (B PI) h as beco me one of the most w i d ely used me asureme nt tool s for as se ssing cl inical p ain.
3 would b e e asil y tra nslated for no n-Engl ish- spea k in g p atients; and (e) w ou ld ca pture not on ly pai n sev erity, b ut a lso the pe rcep tion of how p ain in terfe r ed with dai ly l ife .
5 E arl y V ersi on: The W is c onsi n Br i ef Pai n Q u est ion n air e The fi rst v ersio n of ou r p ain measu re was the Wi sco nsi n Bri ef Pai n Question nair e (BPQ ; Daut & Cleelan d, 1982 ; Daut , Cleel and, & Fla nery, 1983 ) .
7 in cl i nical and r esear ch a ppl icatio ns . The short for m is t ypicall y wha t is refe rred t o when the BPI is ci ted in res earc h, and i t is the ve rsio n we descri be be low. Mo st p syc hometri c ev alua tions of t he BPI hav e been perf ormed o n the sho r t form.
9 from 8 0 cent e rs we r e enroll ed in the study (Cl eeland et al., 199 4 ). Fact o r analy sis ver if ie d t he two separ ate fa ctors, pain se v er i t y an d interf e r ence, fo und in th e pr e v iou s study . Internal stabil i t y (Cr o nb a c h al ph a) was also exam in e d in th is st u dy .
11 Tes t-Retes t Rel i abili ty and Alte rnate-Fo rms Reli ability : the Hindi T r an s la ti o n Fin all y , on e st udy comb ined an e xam i nat i on of bot h t est -r e t est rel i ab i l i ty a nd altern ate-f orms reliab i lit y (Saxena et al ., 1999 ) .
13 cl i nical tr ials: IMMPAC T recomm endation s. J Pa in 9(2 ): 105-121, 2 /2008. Food and Dru g Adminis tr ation. Gui del ines for Indust ry (draft ). Pat i e nt - Reported O utcome Mea sures: Use in Med ical Produ ct Deve l opmen t to Sup port Labeling C laims.
15 Chapt er 2 BPI Ref erenc e s: Use of the B P I in Various St udies The B r ief Pai n I n ve ntory h as been use d in more tha n 4 00 s t udie s worldwi de. Here w e prese n t BPI refer ences cat egor ized b y type of s t udy. Can cer Bo ne P ai n .
17 in du ced pain flar e after pall iat ive r a d iot herapy for bone met astases-a pilot st udy. Sup port Care Canc er 15 (6): 643-647 , 6 /2007. 8. Cleel and CS. The m easurem e nt o f pain f rom m etast at ic b one d iseas e: capt uring t he patient ' s e xperie n ce.
19 met astases in cancer pat ients]. Nippon Iga ku Ho sha sen Gakk ai Zassh i 65(4 ): 399-410 , 1 0 /2005. 24. Pi stev ou-G ompaki K, Kou lou lias V E, V arv eri s C, Mys takid ou K, Georg akop oulo s G, E lef theria dis N , Gomp akis N, Ko uv aris J .
21 9. Ho ltan A , Aass N, N ordoy T, Haugen DF, Ka asa S, Mo hr W, Ko ng s ga ard UE. Pre valen c e o f pain in hosp italised can cer pat i e nts i n N o r w a y: a nat i o nal su r v ey. P all i at Med 21(1): 7-13, 1 /2007. 10. Kong sgaard UE, Holta n A, Aa ss N.
23 Cooperat iv e On cology Grou p. Ann O ncol 16( 6 ) : 9 72-980, 6 /2005. 11. Du Pen SL, Du Pen AR , Po l issa r N, Ha nsb erry J , Krayb i ll BM, Sti llma n M, Pank e J , Eve rly R, Sy rj ala K. I m p lemen ti ng gu i d el ines for cancer p ain m anag e m e nt : r esults of a r andomized controlled clinical trial.
25 28. Li ang SY, Ya tes P, Edw ards H , Ts ay SL. Facto r s inf luenci ng op io id -ta k in g sel f-efficac y and an alg esic adh erence in Ta iwa nese outp atient s with ca nce r .
27 mor ph i n e p r e-tre ated an d o pioi d n aive pat ients w ith tr ansdermal f entanyl. Int J Ca ncer 107(3 ): 486-49 2, 11 /2003. 46. Mysta k i d ou K, Par pa E, Kat souda E , Gala nos A, V laho s L. Influ ence o f p a i n an d qual i ty of l ife on desir e for h ast ened death in patie nts with advanced cance r.
29 popula tion of men with pros ta te cance r. B r J Ca ncer 85(4) : 4 97-50 3, 8/2001. 62. Sa ndb lom G , Car lsson P, Sennf alt K , V arenho rs t E. A populatio n-base d study of pain an d qu a lity of life du r ing the year befor e d e ath in m en wi t h prost ate can cer.
31 Depressive Disorders 1. Bran nan S K, M allinc krod t CH, B rown EB, Wo hlreic h M M, Watkin JG, Sc hatzb erg A F . Dulox eti ne 6 0 mg onc e -d ai ly in the tr e atm ent of pain fu l physical symptom s in pat ients wi t h m ajo r dep r e ssi v e dis o rde r.
33 7. Schif f m ann R , K opp JB , Austin H A, I II, Sabni s S, M oore D F, Weibel T, Ba low JE , Bra dy RO. En zyme r e place ment the r apy i n Fa bry dis ea se: a r ando mi ze d co ntr oll ed t r ial. JA MA 285 (21 ): 2 743-2 749, 6/200 1. F ib romy a lg ia 1.
35 8. New shan G, L efko w itz M. Tran sderm al fent anyl f o r chronic pain in AID S: a pi lo t study . J Pai n Symp tom Manage 21(1): 69- 7 7, 1/2001 .
37 8. Chae J , M asca renhas D , Yu D T, Ki rstein s A , Elovi c EP , F lan agan SR , Harv ey RL, Z orow it z RD, F ang ZP. Pos ts troke shou lder pain : its re la tionshi p to moto r i mpai rmen t, acti vi ty limi ta ti on, and qual i ty of life. A rc h P hys Med Rehabil 88(3 ) : 2 98-301, 3 /2007.
39 28. Renzen brink G J, IJz erman MJ. Per cutaneo us ne uromus cular electr i cal stimulation (P-NMES) for tr eating shoulde r pain in chro nic he mip legi a. Effe cts on sho u lder pai n and q ua lity of l i fe. Cl i n Re habil 18 (4) : 359-365, 6 / 200 4.
41 val proate in p at ients with can cer-r e lat ed neuro pathic p ain. J Pa i n Sym ptom Ma na ge 21(3 ) : 204 - 2 09, 3/2001. 9. Ka tz N P, Ga mmaito ni AR, Da vis MW, D wo rkin R H. Lidoc aine pat ch 5 % r educe s pain int ensity and inter ferenc e w it h quality o f l i fe in patients with post herpet ic neur algia : an ef fectivenes s tr i al.
43 5. Cowan DT, Wilso n-Ba rnett J, Griffi ths P, V aughan D J, G on dhia A, Allan LG. A random ized, double-b l in d, placebo -con trolled, cro ss-over pilot stud y to asse s s the eff ects of long-t.
45 fi ndings f ro m a pilo t s tudy. J Op ioid Manag 3(3) : 145 -154, 5 /2007. 22. Thi e NM , Pras ad NG, Ma jor PW. Ev aluati on of g lucos amin e s ulfate compare d t o ibu profen fo r the tre atm e nt o f tem porom and i b ular joi nt osteoart hr i t i s: a ran do m ized doubl e bli nd contro lled 3 month c lin ica l t ria l .
47 5. Da v ison SN. P ain in hem odialysis pat ients: pre val ence, cau se, s everit y, and m ana gement . A m J Ki dne y Di s 42(6 ): 1239 - 1247, 1 2/2003. 6. Dell D D, We av er C, Ko ze mpel J, B a rsevi ck A. R ecov e ry afte r tr ansvers e r ectus abdom inis m y ocutan eous flap brea s t r econ stru ct io n sur gery.
49 placebo-c ontrolled clinical trial. J E p idem io l B io sta t 5(6 ): 359- 3 65, 200 0. 23. Ti ttle MB, M cMi llan S C, Hag an S. V alid ating the b rief p ain in ven tory f or use wit h surgical patient s with can cer. Oncol N urs For um 30(2 ) : 325 - 330, 3/2003.
51 a cute oncol ogy settin g . A sia-Pa cific Journ al o f Cl inical Onc o lo gy 3(2 ) : 89-94, 6/20 07. 12. Cleelan d CS, Ry an KM. Pain a ssessment: glob a l use of th e Br ief Pain In v ent ory. Ann Acad Med Singap ore 23(2 ): 129-1 3 8, 3 /1994. 13.
53 To o l s: Is th e Conte nt Appr opr iate f or Us e in Pal liati v e Care ? J Pa i n Sym ptom Ma na ge 32(6 ) : 567 - 5 80, 12/2006 . 29. J anjan N A, Payne R, G illi s T, Podolo ff D , L ibshi tz HI, Lenzi R , Ther iault R, M art in C, Ya sko A .
55 the t i m e t rad e-o ff. Jo ur nal of Cl inical E pid em iol ogy 60 ( 10 ): 1 029-1 033, 10/20 07. 46. Ra db ruch L, Loick G, Ki encke P, Li n dena G, S aba towski R , G r ond S, L ehmann KA , Cle el and C S . Val i da t io n of t he Germ an v ersion of th e Brief P ain Inventor y .
57 os teoarth riti c pai n. J Pain Sy mptom M anage 3 1(1): 48-5 7, 1 /2006. 64. Wu EQ , Borton J, Said G, Le TK, Mon z B, Rosi lio M, A voin et S. Est im ated pre v al en ce of per ipheral n eur o p at hy and as so ci at e d p a i n in adult s with diab ete s in Fr anc e.
59 9. U ki J, Me ndo za T, Cl eelan d C S, N akam ura Y , T a keda F. A br ief can cer pa i n a ssessm ent tool in Ja panes e : t he ut i lit y of t he Jap a ne se Br ief P ain Invent ory--BP I-J. J Pain Sym ptom Manage 1 6(6): 3 64-373, 1 2/1998. 10.
61 16. Cleelan d CS. Measurem ent a nd pr ev alen ce of pain in can cer. Sem i n O ncol Nurs 1(2): 8 7-92, 5 / 1985. 17. Cle ela nd CS. How to trea t a "con struc t ". J Pai n Sympt o m Ma nage 1(3): 16 1-162, 1 986. 18. Cleelan d CS, Lad i n s ky JL, Ser lin RC, N ugyen CT.
63 BR, Stau ffe r JW , vo n ST, W hi te RE, Wi tte r J, Z a vis i c S. Int erpretin g th e clinical impor tanc e o f treat ment outcom es in chro nic pai n clinic al tri als : IMM PA CT r e co mmendati ons . J Pain 9 (2): 10 5-121, 2/2008 . 35. Ewi ng G, Todd C, Roge rs M, B arc lay S, M cCabe J , M artin A .
65 51. Li KK, Har ris K, Hadi S, Chow E. W hat shou ld be t h e op tim al cut po int s for m ild, moderat e, and severe pain ? Jour nal of Pall i at iv e M edic ine 10( 6) : 1338 - 1346 , 12 /2007.
67 69. Ta n G, J ense n MP, Tho rnby JI, Sh an t i BF. V ali dation of t he Bri ef Pai n In v ento ry fo r chron ic nonmalig n ant pa in. J Pai n 5(2) : 1 33- 1 37, 3/2 004 . 70. Yun YH , Park YS , Lee ES, Ba ng SM, Heo DS, Pa rk SY, You CH, Wes t K. Vali da t ion of the K orean ve rsion of t he EO R TC QLQ - C30.
デバイスCharles S. Cleeland The Brief Pain Inventory iiの購入後に（又は購入する前であっても）重要なポイントは、説明書をよく読むことです。その単純な理由はいくつかあります：
Charles S. Cleeland The Brief Pain Inventory iiをまだ購入していないなら、この製品の基本情報を理解する良い機会です。まずは上にある説明書の最初のページをご覧ください。そこにはCharles S. Cleeland The Brief Pain Inventory iiの技術情報の概要が記載されているはずです。デバイスがあなたのニーズを満たすかどうかは、ここで確認しましょう。Charles S. Cleeland The Brief Pain Inventory iiの取扱説明書の次のページをよく読むことにより、製品の全機能やその取り扱いに関する情報を知ることができます。Charles S. Cleeland The Brief Pain Inventory iiで得られた情報は、きっとあなたの購入の決断を手助けしてくれることでしょう。
Charles S. Cleeland The Brief Pain Inventory iiを既にお持ちだが、まだ読んでいない場合は、上記の理由によりそれを行うべきです。そうすることにより機能を適切に使用しているか、又はCharles S. Cleeland The Brief Pain Inventory iiの不適切な取り扱いによりその寿命を短くする危険を犯していないかどうかを知ることができます。
ですが、ユーザガイドが果たす重要な役割の一つは、Charles S. Cleeland The Brief Pain Inventory iiに関する問題の解決を支援することです。そこにはほとんどの場合、トラブルシューティング、すなわちCharles S. Cleeland The Brief Pain Inventory iiデバイスで最もよく起こりうる故障・不良とそれらの対処法についてのアドバイスを見つけることができるはずです。たとえ問題を解決できなかった場合でも、説明書にはカスタマー・サービスセンター又は最寄りのサービスセンターへの問い合わせ先等、次の対処法についての指示があるはずです。
